Jean-Michel Boers
Algemeen Directeur bij Boehringer Ingelheim Pharmaceuticals, Inc.
Profiel
Jean-Michel Boers is currently the President & Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc. He previously served as the Chairman & Chief Executive Officer at Boehringer Ingelheim France SASU.
He holds an MBA from The University of Texas at Austin and a graduate degree from Radboud University Nijmegen.
Actieve functies van Jean-Michel Boers
| Bedrijven | Functie | Begin |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Algemeen Directeur | 31-07-2020 |
Eerdere bekende functies van Jean-Michel Boers
| Bedrijven | Functie | Einde |
|---|---|---|
Boehringer Ingelheim France SASU
 Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Algemeen Directeur | - |
Opleiding van Jean-Michel Boers
| The University of Texas at Austin | Masters Business Admin |
| Radboud University Nijmegen | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Boehringer Ingelheim France SASU
Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Health Technology |
